Biospecimen and Bioimaging Core for Prostate Cancer Center
Official title: Core-001
Funded at Stanford University · NIH-11605916 · Data updated 2026-11-12
A centralized Stanford-based core helps cancer researchers access high-quality prostate tissue samples and advanced imaging data to accelerate work on prostate cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | September 15, 2021 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $392,361 |
| NIH project number | 5U54DK130065-06 |
| Project ID | NIH-11605916 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and centers conducting prostate cancer research who need high-quality biospecimens and imaging data.
✕Less likely to help
Direct patient participation is not described; the core primarily supports investigators.
What this research studies
This grant supports a Biospecimen/Bioimaging Core that combines pathology and urology resources to supply investigators with fresh, frozen, and FFPE prostate tissues, along with rich imaging data. It also handles consent, quality control, data management, and regulatory compliance to ensure ethical, well-organized sample use. The core offers tissue characterization methods like histology, tissue microarrays, laser microdissection, and multiplex IHC using MIBI-TOF, plus access to MRI and histology images and a prostate atlas spanning multiple scales. By providing centralized, scalable services, the Core aims to speed discovery and reproducibility across prostate cancer research efforts.
Why it matters
Potential benefit: Patients could benefit indirectly through faster advances in prostate cancer understanding and new diagnostic or therapeutic approaches.
How similar studies have gone: Similar biospecimen and imaging cores have supported translational cancer research with successful data sharing and tissue characterization.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Brooks, James D. — Stanford University
- Study coordinator: Brooks, James D.
Related research
Other NIH-funded projects on the same topics.
-
Multimodal AI to predict CAR-T patient response and guide safer, smarter cell design
A Stanford team is building AI tools that use patient and CAR-T cell data to predict how well a CAR-T therapy will work and what design changes might boost effectiveness and safety for people with cancer.
-
Community-driven model to reduce overdose deaths through smarter resource use
A Stanford-led project uses a data-driven model to help counties pick the best ways to prevent opioid and stimulant overdoses and save lives.
-
Center for Dissemination and Implementation at Stanford: Research Core
A Stanford-based program is advancing how evidence-based addiction treatments are implemented across settings to help people with substance use disorders receive better care.
-
Center for Dissemination and Implementation At Stanford (C-DIAS)
A center-based program at Stanford aims to speed people who need addiction treatments to get evidence-based care.
-
Mitochondrial structure and neuron health in Alzheimer's and ALS
This grant studies how mitochondrial cristae structure in neurons is controlled and how its disruption may contribute to diseases like Alzheimer's and ALS.
-
Pediatric EMS seizures: simpler age-based midazolam dosing
A nationwide trial at EMS agencies tests whether using fixed, age-based dosing of midazolam for seizures in children improves treatment speed and safety.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.